Given the surge in buying (though small) prior to the closing date and after, I would infer that they've just scraped in with the requisite funding. We should know the result next week.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
